"10.1371_journal.pone.0045478","plos one","2012-09-18T00:00:00Z","Annabelle Cesaro; Nadia Anceriz; Audrey Plante; Nathalie Pagé; Mélanie R Tardif; Philippe A Tessier","Centre de recherche en Infectiologie, Centre de recherche du Centre Hospitalier Universitaire de Quebec, and Faculty of Medecine, Université Laval, Quebec, Canada","Conceived and designed the experiments: AC NA AP NP MRT PAT. Performed the experiments: AC NA AP NP MRT PAT. Analyzed the data: AC NA AP NP MRT PAT. Wrote the paper: AC NA MRT PT.","P.A.T. is the founder of InflammatoRx Inc., which is developing anti-S100A9 antibodies for commercial purposes. The other authors have declared that no competing interests exists. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","09","Annabelle Cesaro","AC",6,FALSE,6,6,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
